Related Experiment Video
Updated: Mar 9, 2026
06:21
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
9.2K
Virus, Oncolytic Virus and Human Prostate Cancer
Guang Bin Liu1, Liang Zhao2, Lifang Zhang3
1School of Health and Wellbeing, Faculty of Health, Engineering and Sciences, The University of Southern Queensland, Toowoomba QLD, 4350, Australia.
Current Cancer Drug Targets
|December 21, 2016
Summary
Virus infections are linked to prostate cancer (PCa) development. Oncolytic virotherapy, using engineered viruses to target and destroy cancer cells, shows promise as a novel treatment for PCa.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Prostate cancer (PCa) is a significant cause of cancer death in men.
- While age and family history are known risk factors, the exact causes of PCa remain unclear.
- Existing treatments like chemotherapy and radiotherapy have limitations due to toxicity and lack of specificity.
Purpose of the Study:
- To review the role of viral infections in prostate cancer pathogenesis.
- To summarize the advancements in oncolytic virotherapy for prostate cancer treatment.
Main Methods:
- Literature review focusing on the link between virus infection and PCa.
- Analysis of studies on the development and application of oncolytic virotherapy for PCa.
Main Results:
- Evidence suggests viral infections, including RXMV and HPV, contribute to prostate tumor development and patient survival.
- Oncolytic virotherapy utilizes live viruses to selectively target and kill cancer cells, offering a more attractive alternative to traditional therapies.
- Genetically engineered oncolytic viruses can induce cancer cell lysis via replication and expression of cytotoxic proteins.
Conclusions:
- Oncolytic virotherapy is an emerging cancer treatment strategy using oncotropic viruses to eliminate malignant cells.
- Despite its potential, challenges remain in the clinical application of oncolytic viruses for prostate cancer therapy.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
01:51Mechanisms of Retrovirus-induced Cancers
7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K